Literature DB >> 36163267

Total synthesis of structurally diverse pleuromutilin antibiotics.

Olivia Goethe1, Mikaela DiBello1, Seth B Herzon2,3.   

Abstract

The emergence of drug-resistant bacterial pathogens has placed renewed emphasis on the total chemical synthesis of novel antibacterials. Tetracyclines, macrolides, streptogramins and lincosamides are now accessible through flexible and general synthetic routes. Pleuromutilins (antibiotics based on the fungal metabolite pleuromutilin) have remained resistant to this approach, in large part due to the difficulties encountered in the de novo construction of the decahydro-3a,9-propanocyclopenta[8]annulene skeleton. Here we present a platform for the total synthesis of pleuromutilins that provides access to diverse derivatives bearing alterations at previously inaccessible skeletal and peripheral positions. The synthesis is enabled by the serendipitous discovery of a vinylogous Wolff rearrangement, which serves to establish the C9 quaternary centre in the targets, and the development of a highly diastereoselective butynylation of an α-quaternary aldehyde, which forms the C14 secondary alcohol. The versatility of the route is demonstrated through the synthesis of seventeen structurally distinct derivatives, with many possessing potent antibacterial activity.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 36163267     DOI: 10.1038/s41557-022-01027-7

Source DB:  PubMed          Journal:  Nat Chem        ISSN: 1755-4330            Impact factor:   24.274


  21 in total

1.  Synthesis and activity of a C-8 keto pleuromutilin derivative.

Authors:  Dane M Springer; Margaret E Sorenson; Stella Huang; Timothy P Connolly; Joanne J Bronson; James A Matson; Ronald L Hanson; David B Brzozowski; Thomas L LaPorte; Ramesh N Patel
Journal:  Bioorg Med Chem Lett       Date:  2003-05-19       Impact factor: 2.823

Review 2.  Antibacterial properties and clinical potential of pleuromutilins.

Authors:  Olivia Goethe; Abigail Heuer; Xiaoshen Ma; Zhixun Wang; Seth B Herzon
Journal:  Nat Prod Rep       Date:  2018-07-06       Impact factor: 13.423

Review 3.  Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics.

Authors:  Fan Liu; Andrew G Myers
Journal:  Curr Opin Chem Biol       Date:  2016-04-01       Impact factor: 8.822

Review 4.  Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance.

Authors:  Susanne Paukner; Rosemarie Riedl
Journal:  Cold Spring Harb Perspect Med       Date:  2017-01-03       Impact factor: 6.915

5.  Susceptibility of bacteria isolated from pigs to tiamulin and enrofloxacin metabolites.

Authors:  Anne Kruse Lykkeberg; Bent Halling-Sørensen; Lars Bogø Jensen
Journal:  Vet Microbiol       Date:  2006-11-26       Impact factor: 3.293

6.  Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin.

Authors:  Daniel R Gentry; Stephen F Rittenhouse; Lynn McCloskey; David J Holmes
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

7.  Unraveling the Metabolic Routes of Retapamulin: Insights into Drug Development of Pleuromutilins.

Authors:  Feifei Sun; Huiyan Zhang; Gerard Bryan Gonzales; Jinhui Zhou; Yi Li; Jinzhen Zhang; Yue Jin; Zhanhui Wang; Yanshen Li; Xingyuan Cao; Suxia Zhang; Shupeng Yang
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

8.  Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity.

Authors:  Chen Davidovich; Anat Bashan; Tamar Auerbach-Nevo; Rachel D Yaggie; Richard R Gontarek; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-08       Impact factor: 11.205

Review 9.  Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic.

Authors:  Michael P Veve; Jamie L Wagner
Journal:  Pharmacotherapy       Date:  2018-08-20       Impact factor: 4.705

10.  A platform for the discovery of new macrolide antibiotics.

Authors:  Ian B Seiple; Ziyang Zhang; Pavol Jakubec; Audrey Langlois-Mercier; Peter M Wright; Daniel T Hog; Kazuo Yabu; Senkara Rao Allu; Takehiro Fukuzaki; Peter N Carlsen; Yoshiaki Kitamura; Xiang Zhou; Matthew L Condakes; Filip T Szczypiński; William D Green; Andrew G Myers
Journal:  Nature       Date:  2016-05-19       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.